# Sitagliptin and Brown Adipose Tissue

> **NCT02294084** · PHASE4 · COMPLETED · sponsor: **Ingrid Jazet** · enrollment: 30 (actual)

## Conditions studied

- Neoplasms, Adipose Tissue

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02294084
- **Lead sponsor:** Ingrid Jazet
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-10
- **Final completion:** 2016-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02294084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02294084, "Sitagliptin and Brown Adipose Tissue". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02294084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*